Results 191 to 200 of about 48,816 (201)

Pharmacokinetics of mitomycin C in rabbit and human

Cancer Chemotherapy and Pharmacology, 1982
John S Kovach, Kovach John S
exaly  

Urinary pH Is Highly Associated With Tumor Recurrence During Intravesical Mitomycin C Therapy for Nonmuscle Invasive Bladder Tumor

Journal of Urology, 2011
Eiji Kikuchi, Kazuhiro Matsumoto, Mototsugu Oya   +2 more
exaly  

Mitomycin C.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1976
openaire   +1 more source

Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and Toxicity

Journal of Urology, 2003
exaly  

Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes

Canadian Journal of Ophthalmology, 2006
Sanjay K Murthy, Karim F Damji, William G Hodge   +2 more
exaly  

KW-2149 (7-N-[2-[Y-L-glutamylamino]ethyldithioethyl]mitomycin C) a new mitomycin c analogue activated by serum

Biochemical Pharmacology, 1997
John R W Masters, John A Hartley, Lloyd R Kelland   +2 more
exaly  

Mitomycin C.

Cancer chemotherapy and biological response modifiers, 1995
N W, Gibson, R M, Phillips, D, Ross
openaire   +1 more source

Mitomycin C

openaire   +1 more source

Mitomycin C.

IARC monographs on the evaluation of the carcinogenic risk of chemicals to man, 1977
openaire   +1 more source

Mitomycin C

2008
openaire   +1 more source